This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Estonia, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, UK.
The drug ZOSTAVAX contains one active pharmaceutical ingredient (API):
1
|
UNII
GPV39ZGD8C - VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
|
|
Varicella-zoster virus vaccine was shown to boost VZV-specific immunity, which is thought to be the mechanism by which it protects against zoster and its complications. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| ZOSTAVAX Powder and solvent for suspension for injection | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J07BK02 | Zoster, live attenuated | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BK Varicella zoster vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 525514020016502 |
| CA | Health Products and Food Branch | 02375516 |
| EE | Ravimiamet | 1276578, 1276589, 1276590, 1276602, 1276613 |
| ES | Centro de información online de medicamentos de la AEMPS | 06341011 |
| FR | Base de données publique des médicaments | 60956323 |
| GB | Medicines & Healthcare Products Regulatory Agency | 201106 |
| HK | Department of Health Drug Office | 55419 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 7064 |
| IT | Agenzia del Farmaco | 037313018, 037313020, 037313032, 037313044, 037313057, 037313069, 037313071, 037313083, 037313095, 037313107, 037313119, 037313121, 037313133 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1031525, 1031526, 1031527, 1031528, 1031529, 1031530, 1031531, 1031532, 1031533, 1031534, 1031535 |
| NL | Z-Index G-Standaard | 15368696 |
| NL | Z-Index G-Standaard, PRK | 86576 |
| NZ | Medicines and Medical Devices Safety Authority | 12140 |
| PL | Rejestru Produktów Leczniczych | 100353400 |
| SG | Health Sciences Authority | 13564P |
| US | FDA, National Drug Code | 0006-4963 |
| ZA | Health Products Regulatory Authority | 44/30.1/0058 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.